Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Classical and Alternative Activation of Cyanobacterium Oscillatoria sp. Lipopolysaccharide-Treated Rat Microglia in vitro.

Mayer AM, Murphy J, MacAdam D, Osterbauer C, Baseer I, Hall ML, Feher D, Williams P.

Toxicol Sci. 2016 Feb;149(2):484-95. doi: 10.1093/toxsci/kfv251.

2.

Synthesis and preliminary biological evaluation of a small library of hybrid compounds based on Ugi isocyanide multicomponent reactions with a marine natural product scaffold.

Avilés E, Prudhomme J, Le Roch KG, Franzblau SG, Chandrasena K, Mayer AM, Rodríguez AD.

Bioorg Med Chem Lett. 2015 Nov 15;25(22):5339-43. doi: 10.1016/j.bmcl.2015.09.033.

3.

Vibrio vulnificus MO6-24/O lipopolysaccharide stimulates superoxide anion, thromboxane B₂, matrix metalloproteinase-9, cytokine and chemokine release by rat brain microglia in vitro.

Mayer AM, Hall ML, Holland M, De Castro C, Molinaro A, Aldulescu M, Frenkel J, Ottenhoff L, Rowley D, Powell J.

Mar Drugs. 2014 Mar 26;12(4):1732-56. doi: 10.3390/md12041732.

4.

Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity.

Jiménez-Romero C, Mayer AM, Rodríguez AD.

Bioorg Med Chem Lett. 2014 Jan 1;24(1):344-8. doi: 10.1016/j.bmcl.2013.11.008.

6.

Marine sponge Hymeniacidon sp. amphilectane metabolites potently inhibit rat brain microglia thromboxane B2 generation.

Mayer AM, Avilés E, Rodríguez AD.

Bioorg Med Chem. 2012 Jan 1;20(1):279-82. doi: 10.1016/j.bmc.2011.10.086.

7.

Cyanobacterial Microcystis aeruginosa lipopolysaccharide elicits release of superoxide anion, thromboxane B₂, cytokines, chemokines, and matrix metalloproteinase-9 by rat microglia.

Mayer AM, Clifford JA, Aldulescu M, Frenkel JA, Holland MA, Hall ML, Glaser KB, Berry J.

Toxicol Sci. 2011 May;121(1):63-72. doi: 10.1093/toxsci/kfr045.

PMID:
21362633
8.
9.

The odyssey of marine pharmaceuticals: a current pipeline perspective.

Mayer AM, Glaser KB, Cuevas C, Jacobs RS, Kem W, Little RD, McIntosh JM, Newman DJ, Potts BC, Shuster DE.

Trends Pharmacol Sci. 2010 Jun;31(6):255-65. doi: 10.1016/j.tips.2010.02.005. Review.

PMID:
20363514
11.

Granulocytic differentiation of HL-60 promyelocytic leukemia cells is associated with increased expression of Cul5.

Baxter SS, Carlson LA, Mayer AM, Hall ML, Fay MJ.

In Vitro Cell Dev Biol Anim. 2009 May-Jun;45(5-6):264-74. doi: 10.1007/s11626-008-9163-4.

PMID:
19118439
12.

Marine pharmacology in 2005-2006: antitumour and cytotoxic compounds.

Mayer AM, Gustafson KR.

Eur J Cancer. 2008 Nov;44(16):2357-87. doi: 10.1016/j.ejca.2008.07.001. Review.

15.

Marine pharmacology in 2003-2004: anti-tumour and cytotoxic compounds.

Mayer AM, Gustafson KR.

Eur J Cancer. 2006 Sep;42(14):2241-70. Review.

PMID:
16901686
17.

Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines.

Mayer AM, Hall ML, Lynch SM, Gunasekera SP, Sennett SH, Pomponi SA.

BMC Pharmacol. 2005 Mar 11;5:6.

18.

Marine pharmacology in 2001-2: antitumour and cytotoxic compounds.

Mayer AM, Gustafson KR.

Eur J Cancer. 2004 Dec;40(18):2676-704. Review.

PMID:
15571951
20.

Marine pharmacology in 2000: antitumor and cytotoxic compounds.

Mayer AM, Gustafson KR.

Int J Cancer. 2003 Jun 20;105(3):291-9. Review.

Items per page

Supplemental Content

Loading ...
Support Center